As of January 2025, Hubei Jumpcan Pharmaceutical has a market cap of $3.80B. This makes Hubei Jumpcan Pharmaceutical the world's 3250th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.33B | 9.04% |
2023 | $3.97B | 15.47% |
2022 | $3.44B | -3.95% |
2021 | $3.58B | 40.09% |
2020 | $2.56B | -16.34% |
2019 | $3.06B | -27.89% |
2018 | $4.24B | -12.11% |
2017 | $4.82B | 22.04% |
2016 | $3.95B | 13.02% |
2015 | $3.49B | 40.41% |
2014 | $2.49B | -1.20% |
2013 | $2.52B | 201.21% |
2012 | $836.40M | 3.60% |
2011 | $807.34M | -33.23% |
2010 | $1.21B | 20.32% |
2009 | $1.00B | 132.88% |
2008 | $431.51M | -52.46% |
2007 | $907.73M | 100.43% |
2006 | $452.89M | 5.43% |
2005 | $429.57M | -16.60% |
2004 | $515.10M | -23.41% |
2003 | $672.54M | -38.49% |
2002 | $1.09B | -30.47% |
2001 | $1.57B | - |